Abstract: Protection of a kernel from a sniff and code reuse attack. A kernel mode page table in initialized in a kernel. The kernel page entries in the kernel mode page table are set from s-pages to u-pages. Supervisor mode access prevention is enabled in the u-pages. Code contained in the kernel page entries in the u-pages is executed, the kernel page entries in the u-pages are capable of execution but are not capable of being accessed and read directly.

Abstract: A display panel and a display apparatus are provided in the present disclosure. The display panel includes a plurality of pixel units. At least one pixel unit includes a display region and an anti-peep region. The anti-peep region includes a first light-blocking layer and a second light-blocking layer; and along a direction perpendicular to the light-exiting surface of the display panel, a distance between the first light-blocking layer and the second light-blocking layer is greater than zero. The first light-blocking layer includes at least one first light-blocking strip and at least one first opening. The second light-blocking layer includes at least one second light-blocking strip and at least one second opening. A vertical projection of a first or second opening on the light-exiting surface of the display panel is within a vertical projection of a corresponding first or second light-blocking strip on the light-exiting surface of the display panel.

Abstract: Antimicrobial cationic polycarbonates and polyurethanes have been prepared comprising one or more pendent guanidinium and/or isothiouronium groups. Additionally, antimicrobial particles were prepared having a silica core linked to surface groups comprising a guanidinium and/or isothiouronium group. The cationic polymers and cationic particles can be potent antimicrobial agents against Gram-negative microbes, Gram-positive microbes, and/or fungi.

Abstract: Translucency of a yttria-stabilized zirconia ceramic is improved to achieve even higher translucency than what is currently offered on the market, without greatly altering its mechanical properties. The enhancement is done by incorporating magnesium-containing dopants into the microstructure of yttria-stabilized zirconia ceramic dental ceramics.

Abstract: Systems and methods for secure mobile checkouts are disclosed. The system may include a secure mobile checkout device configured to scan products available in a merchant store. The device may scan the product to determine a product identifier. The device may transmit the scanned product data to a checkout application to retrieve product data corresponding to the product identifier. In device may initiate a transaction with a payment network to purchase the product, based on the product data provided by the checkout application. The payment network may process the transaction, and may authorize the purchase with the merchant.

Abstract: A parameterless and position-sensorless MTPA control of a permanent magnet synchronous motor including: using three rotating reference frames having different observation angles to parse the current vector; using a target current value and a preset current-rotor angle y that is between the current vector and the qr-axis of the (dr, qr) rotor reference frame to obtain the angles between the current vector, the voltage vector, and the rotor position; obtaining the target voltage value and the target voltage angle by using the obtained angles to obtain the target phase voltage values for regulation. The method is simple in controlling the motor, improves the control efficiency and reliability, and improves the control accuracy.

Abstract: A method of calibrating a motor assembly includes selecting an electric motor and a motor controller for the motor assembly, obtaining at least one electric motor parameter of the electric motor, calculating a correction factor for the electric motor based upon the at least one electric motor parameter, and programming the motor controller with the correction factor.

Abstract: Establishing a communication channel via a relay server with reduced setup time. Upon request by an initiating communication device a relay allocation server may allocate a single relay server for use in a communication session between the initiating communication device and one or more recipient communication devices. The relay server may be selected to perform favorably for the initiating communication device. Messaging for establishment of the communication session may be performed using persistent messaging connections, to avoid connection establishment cost. Messaging may also be performed using address tokens to avoid the cost of discovering global IP addresses. Following establishment of the communication session, the relay server may discover the IP address of one or more recipient communication devices, and may initiate reallocation of those devices to another relay server.

Abstract: The invention discloses compounds for treatment or prevention of liver diseases. The compounds are compounds represented by a formula (I) or (II), optical isomers or pharmaceutically acceptable salts of the compounds. The compounds and optical isomers or pharmaceutically acceptable salts of the compounds can be applied to preparation of drugs for treatment or prevention of liver diseases.

Abstract: A water-soluble polymer having an aliphatic polycarbonate backbone, a first carbonate monomer with at least one hydrophilic functionality, and a second carbonate monomer with at least one hydrophobic functionality is able to completely and quickly eliminate a virus from a human and/or animal cell. The at least one hydrophilic functionality is a sulfate, a sulfonate, a carboxylate, and/or a phosphate and the at least one hydrophobic functionality is an alkyl. The hydrophilic/hydrophobic functionalities of the polymer may be tuned to enhance the antiviral properties of the polymer and/or to decrease any cytotoxicity associated with the application of the polymer to a human and/or animal cell. The antiviral polymer is biocompatible and biodegradable.

Abstract: A method of calibrating a motor assembly includes selecting an electric motor and a motor controller for the motor assembly, obtaining at least one electric motor parameter of the electric motor, calculating a correction factor for the electric motor based upon the at least one electric motor parameter, and programming the motor controller with the correction factor.

Abstract: Techniques regarding chemical compounds with antimicrobial functionality are provided. For example, one or more embodiments describe herein can comprise a monomer that can comprise a molecular backbone. The molecular backbone can comprise a bis(urea)guanidinium structure covalently bonded to a functional group, which can comprise a radical. Also, the monomer can have supramolecular assembly functionality.

Abstract: The present disclosure discloses a display device. The display device includes a first display structure, a second display structure and a backlight device. The first display structure includes first pixels arranged in an array, the first pixels are divided into multiple dimming areas, and each dimming area includes at least one first pixel. The first display structure is for adjusting the transmittance of each dimming area for lights emitted by the backlight device according to an image to be displayed in the next frame of the second display structure.

Abstract: The present invention relates to pyrrolo-aromatic heterocyclic compounds, a preparation method therefor and medical use thereof. Particularly, the present invention relates to a compound represented by formula I, a preparation method therefor, a pharmaceutical composition comprising the compound, and use of the compound as a BTK kinase inhibitor. The compound and the pharmaceutical composition comprising same can be used for the treating diseases associated with BTK kinase activity, such as inflammations, autoimmune disorders, and cancers. The definition of each substituent in formula I is the same as that in the description.

Abstract: The present invention belongs to the field of medicinal chemistry. Specifically disclosed is a class of URAT1 inhibitors for promoting uric acid excretion, which are compounds as represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. Experiments show that the compounds provided by the present invention have a very good inhibitory effect on the transport of uric acid by hURAT1 in HEK293 transfected cells, and that such compounds have a good application prospect in the treatment of hyperuricemia or gout.

Abstract: Disclosed are an indoor non-contact human activity recognition method and system. The method comprises: collecting an indoor reflected signal by using an antenna array; filtering the reflected signal to obtain a noise-removed reflection signal; and inputting the noise-removed reflected signal to a pre-trained human activity recognition model, and determining a human activity category, the human activity recognition model being a pre-trained CNN network model based on a transfer learning algorithm. The recognition method and system have the advantages that: the antenna array is configured for collecting human actions to carry out activity recognition indoors, which can be applied to home-based care scenes; original data is denoised, so that most of high-frequency noises can be removed, and a phase change of the signal is reserved; a CNN structure is adopted for training so as to reduce a complexity of the system location-free sensing.

Abstract: The present disclosure provides a method for treating depression using a therapeutically effective amount of a pharmaceutical agent. The pharmaceutical agent can inhibit an activity of an astroglial potassium channel, and especially inhibit the functionality of Kir4.1, in astrocytes in the lateral habenula of a subject so that the abnormal burst firings of neurons in the lateral habenula of the subject can be suppressed. The pharmaceutical agent can include a vector expressing a target nucleotide sequence in the astrocytes in the lateral habenula, whose expression is configured to suppress Kir4.1 expression by RNA interference, or to block Kir4.1 functionality by a dominant negative effect of a mutant Kir4.1 protein. The pharmaceutical agent can alternatively comprise a small molecule compound, or an active macromolecule such as an anti-Kir4.1 antibody, that can directly inhibit the astroglial potassium channel activity.

Abstract: A piece picking system includes at least one main conveyor unit and a plurality of sorting modules. The at least one main conveyor unit and the plurality of sorting modules are arranged crosswise in a matrix, and the at least one main conveyor unit is located above or below the plurality of sorting modules. A plurality of picking stations are arranged at a side of each main conveyor unit, and are adjacent to each of the sorting modules. The main conveyor unit is configured to convey a first container carrying an item to be picked. The picking station is configured to pick the item in a required quantity from the first container conveyed by the main conveyor unit according to an order requirement. The sorting module is configured to sort the item picked by the adjacent picking station. The system aggregates the sorting capabilities of the plurality of sorting modules.

Abstract: Antibacterial coatings and methods of making the antibacterial coatings are described herein. A first branched polyethylenimine (BPEI) layer is formed and a first glyoxal layer is formed on a surface of the BPEI layer. The first BPEI layer and the first glyoxal layer are cured to form a crosslinked BPEI coating. The first BPEI layer can be modified with superhydrophobic moieties, superhydrophilic moieties, or negatively charged moieties to increase the antifouling characteristics of the coating. The first BPEI layer can be modified with contact-killing bactericidal moieties to increase the bactericidal characteristics of the coating.

Abstract: Techniques regarding post polymerization modifications to polycarbonate polymers via a flow reactor are provided. For example, one or more embodiments described herein can comprise a cyclic carbonate monomer that can be employed to facilitate polymerization of one or more polycarbonate platforms susceptible to post polymerization modification. For instance, one or more embodiments can regard a cyclic carbonate molecular backbone covalently bonded to an aryl halide functional group via in accordance with a chemical structure selected from the group consisting of: In the chemical structures, “R1” can be selected from the group consisting of a hydrogen atom and a functional group comprising a first alkyl group; “L” can represent a linkage group, comprising: a second alkyl group and an end group having at least one member selected from the group consisting of an oxygen atom and a nitrogen atom; and “A” can represent the aryl halide functional group.